| MeSH term | MeSH ID | Detail |
|---|---|---|
| Measles | D008457 | 3 associated lipids |
| Malocclusion | D008310 | 3 associated lipids |
| Hyperparathyroidism | D006961 | 3 associated lipids |
| Carcinoma, Lobular | D018275 | 4 associated lipids |
| Mitral Valve Insufficiency | D008944 | 4 associated lipids |
| Osteoarthritis, Hip | D015207 | 4 associated lipids |
| Temporomandibular Joint Disorders | D013705 | 4 associated lipids |
| Actinobacillus Infections | D000189 | 4 associated lipids |
| Periapical Diseases | D010483 | 4 associated lipids |
| Diabetes Complications | D048909 | 4 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wiercinska-Drapalo A et al. | Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients. | 2005 | Prostaglandins Other Lipid Mediat. | pmid:16303613 |
| Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
| Kuroyanagi G et al. | Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. | 2014 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:24813642 |
| Fujita D et al. | Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. | 2003 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12711253 |
| Malik P et al. | Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. | 2013 | Prog. Neuropsychopharmacol. Biol. Psychiatry | pmid:23380173 |
| Cozzani M et al. | Transcription Factor Decoy (TFD) as a novel approach for the control of osteoclastic resorption. | 2005 | Prog Orthod | pmid:16276433 |
| Ta HM et al. | Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21059944 |
| Yasuda H et al. | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9520411 |
| Hsu H et al. | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:10097072 |
| Shimamura M et al. | OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:24847069 |
| Xiong L et al. | Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. | 2015 | Proc. Natl. Acad. Sci. U.S.A. | pmid:25733894 |
| Duheron V et al. | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21402940 |
| Chen W et al. | Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:24733914 |
| Wei W et al. | Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22315431 |
| Krause U et al. | Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20150512 |
| Pearse RN et al. | Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11562486 |
| Raffai RL et al. | Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11553788 |
| Toraldo G et al. | IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. | 2003 | Proc. Natl. Acad. Sci. U.S.A. | pmid:12490655 |
| Li JY et al. | Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21187391 |
| Baud'huin M et al. | A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22761317 |
| Wang Y et al. | Chicken receptor activator of nuclear factor-kappaB ligand induces formation of chicken osteoclasts from bone marrow cells and also directly activates mature osteoclasts. | 2008 | Poult. Sci. | pmid:18931186 |
| Jiang S et al. | Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. | 2013 | Poult. Sci. | pmid:23687138 |
| Fu YX et al. | Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. | 2013 | Poult. Sci. | pmid:23687158 |
| Ostrowska Z et al. | Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. | 2011 | Postepy Hig Med Dosw (Online) | pmid:22100799 |
| Ostrowska Z | [Menopause, obesity, and bone status]. | 2009 | Postepy Hig Med Dosw (Online) | pmid:19252463 |
| Ostrowska Z et al. | Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. | 2013 | Postepy Hig Med Dosw (Online) | pmid:23752595 |
| Zdzisińska B and Kandefer-Szerszeń M | [The role of RANK/RANKL and OPG in multiple myeloma]. | 2006 | Postepy Hig Med Dosw (Online) | pmid:17013366 |
| Majerczyk M et al. | [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. | 2015 | Postepy Hig Med Dosw (Online) | pmid:27259222 |
| Stanisławowski M and Kmieć Z | [The participation of RANK, RANKL and OPG in tumor osteolysis]. | 2009 | Postepy Hig Med Dosw (Online) | pmid:19502684 |
| Ostrowska Z et al. | Â Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. | 2012 | Postepy Hig Med Dosw (Online) | pmid:23001207 |
| Ambroszkiewicz J et al. | [Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria]. | 2008 | Pol. Merkur. Lekarski | pmid:18839616 |
| Kmieć Z and Sokołowska I | [Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis--new therapeutical opportunities]. | 2007 | Pol. Merkur. Lekarski | pmid:17684931 |
| Hen K et al. | [Osteoprotegerin--a new atherosclerosis marker]. | 2011 | Pol. Merkur. Lekarski | pmid:22097184 |
| Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
| Janda K et al. | Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. | 2013 | Pol. Arch. Med. Wewn. | pmid:23535831 |
| Nehring P et al. | Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex‑specific rs2073618 polymorphism as a risk factor for diabetic foot. | 2013 | Pol. Arch. Med. Wewn. | pmid:23299915 |
| Jasiewicz M et al. | Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. | 2014 | Pol. Arch. Med. Wewn. | pmid:25188298 |
| Stajszczyk M | [Role of receptor activator of nuclear factor kappa B (RANK), its ligand (RANK-L) and osteoprotegerin (OPG) in bone metabolism]. | 2002 | Pol. Arch. Med. Wewn. | pmid:12600190 |
| Adamczyk T et al. | Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease. | 2012 | Pol. Arch. Med. Wewn. | pmid:22237719 |
| Titanji K et al. | Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. | 2014 | PLoS Pathog. | pmid:25393853 |
| Shah AP et al. | Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. | 2016 | PLoS ONE | pmid:27019421 |
| Funck-Brentano T et al. | Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. | 2012 | PLoS ONE | pmid:22432033 |
| Zhang Y et al. | Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. | 2011 | PLoS ONE | pmid:21897843 |
| Peng X et al. | Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. | 2013 | PLoS ONE | pmid:23516466 |
| D'Abramo A et al. | Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. | 2016 | PLoS ONE | pmid:26913505 |
| Kuroda Y et al. | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. | 2016 | PLoS ONE | pmid:26751951 |
| Plasilova M et al. | Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). | 2011 | PLoS ONE | pmid:21738662 |
| Liu W et al. | Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. | 2015 | PLoS ONE | pmid:26571489 |
| Weiss RM et al. | Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. | 2013 | PLoS ONE | pmid:23762316 |
| Roato I et al. | Osteoclasts are active in bone forming metastases of prostate cancer patients. | 2008 | PLoS ONE | pmid:18978943 |
| Pan X et al. | Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. | 2015 | PLoS ONE | pmid:26334877 |
| Silva Vde O et al. | β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. | 2015 | PLoS ONE | pmid:26291983 |
| Yang DC et al. | cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. | 2008 | PLoS ONE | pmid:18253488 |
| Gennaro G et al. | Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats. | 2015 | PLoS ONE | pmid:26270535 |
| Zhang J et al. | Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. | 2013 | PLoS ONE | pmid:23936431 |
| Grosjean F et al. | Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. | 2015 | PLoS ONE | pmid:26247358 |
| Lewis JR et al. | Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. | 2015 | PLoS ONE | pmid:26222774 |
| Stalvey MS et al. | Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. | 2013 | PLoS ONE | pmid:24236172 |
| Wang J et al. | RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. | 2015 | PLoS ONE | pmid:26218592 |
| Loiselle AE et al. | Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice. | 2013 | PLoS ONE | pmid:24260576 |
| Lin C et al. | The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. | 2013 | PLoS ONE | pmid:23469146 |
| Morena M et al. | Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients. | 2012 | PLoS ONE | pmid:22567137 |
| Goyden J et al. | The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. | 2015 | PLoS ONE | pmid:26030441 |
| Zhou S et al. | Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. | 2013 | PLoS ONE | pmid:23874840 |
| Ehlken C et al. | Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. | 2015 | PLoS ONE | pmid:25978399 |
| de Araújo Júnior RF et al. | Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. | 2013 | PLoS ONE | pmid:23843954 |
| Jiang W et al. | Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. | 2013 | PLoS ONE | pmid:24116163 |
| Di Bartolo BA et al. | TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. | 2013 | PLoS ONE | pmid:24040204 |
| Wulf-Johansson H et al. | Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions. | 2013 | PLoS ONE | pmid:24349233 |
| Lanza D et al. | Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. | 2015 | PLoS ONE | pmid:25635832 |
| Marano RJ et al. | Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. | 2013 | PLoS ONE | pmid:23667691 |
| Kam WW et al. | The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. | 2012 | PLoS ONE | pmid:22295097 |
| Mabilleau G and Sabokbar A | Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. | 2009 | PLoS ONE | pmid:19137064 |
| Cardelli M and Aubin JE | ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. | 2014 | PLoS ONE | pmid:25313644 |
| Holt V et al. | Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. | 2014 | PLoS ONE | pmid:25302610 |
| Schündeln MM et al. | Impairment of bone health in pediatric patients with hemolytic anemia. | 2014 | PLoS ONE | pmid:25299063 |
| Saito K et al. | Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. | 2013 | PLoS ONE | pmid:23349978 |
| Kebschull M et al. | Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen. | 2013 | PLoS ONE | pmid:23355901 |
| Buckle CH et al. | Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. | 2012 | PLoS ONE | pmid:22952578 |
| Shen P et al. | Expression of osteoprotegerin in placenta and its association with preeclampsia. | 2012 | PLoS ONE | pmid:22952959 |
| Chen YH et al. | Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. | 2012 | PLoS ONE | pmid:22957004 |
| Genre F et al. | Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. | 2014 | PLoS ONE | pmid:25184828 |
| Åšliwicka E et al. | Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. | 2017 | PLoS ONE | pmid:28732027 |
| Bergdolt S et al. | Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. | 2017 | PLoS ONE | pmid:28614388 |
| Liu J et al. | MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. | 2017 | PLoS ONE | pmid:28319142 |
| Yoshida S et al. | An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study. | 2014 | PLoS ONE | pmid:25105978 |
| Shetelig C et al. | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. | 2017 | PLoS ONE | pmid:28253327 |
| Ohlsson C et al. | Probiotics protect mice from ovariectomy-induced cortical bone loss. | 2014 | PLoS ONE | pmid:24637895 |
| Shu R et al. | Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. | 2017 | PLoS ONE | pmid:28081119 |
| Xue Y et al. | Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. | 2012 | PLoS ONE | pmid:23144698 |
| Nolen BM et al. | Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. | 2014 | PLoS ONE | pmid:24747429 |
| Kamata R et al. | EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. | 2016 | PLoS ONE | pmid:27764222 |
| Liu HJ et al. | Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. | 2016 | PLoS ONE | pmid:27764190 |
| O'Sullivan S et al. | Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. | 2016 | PLoS ONE | pmid:27737004 |
| Montes de Oca A et al. | Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. | 2014 | PLoS ONE | pmid:24586847 |
| Zanotti S et al. | Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. | 2014 | PLoS ONE | pmid:24489784 |
| Røysland R et al. | Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. | 2016 | PLoS ONE | pmid:27463973 |
| Caetano-Lopes J et al. | Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. | 2011 | PLoS ONE | pmid:21347301 |
| Tawfeek H et al. | Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. | 2010 | PLoS ONE | pmid:20808842 |
| Zhao JJ et al. | MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. | 2016 | PLoS ONE | pmid:27459539 |